The thiazide-sensitive Na-Cl cotransporter and human disease: Reemergence of an old player

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 538-540

  Ellison, David H ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHLORIDE; SODIUM; THIAZIDE DIURETIC AGENT;

AUTOSOMAL RECESSIVE DISORDER; BLOOD PRESSURE REGULATION; CHLORIDE TRANSPORT; EDITORIAL; GITELMAN SYNDROME; HYPERTENSION; ION TRANSPORT; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SODIUM TRANSPORT;

EID: 0037304768     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Freis ED: Origins and development of antihypertensive drug treatment. In: Hypertension: Pathophysiology, Diagnosis, and Management, edited by Laragh JH, Brenner BM, New York, Raven Press, 1990, pp 2093-2106
2. Ackerman DM, Hook JB: Historical background, chemistry, and classification. In: The Physiological Basis of Diuretic Therapy in Clinical Medicine, edited by Eknoyan G, Martinez-Maldonado M, Orlando, Grune & Stratton, Inc., 1986, pp 1-25
3. Gamba G, Saltzberg SN, Lombardi M, Miyanoshita A, Lytton J, Hediger MA, Brenner BM, Hebert SC: Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA 90: 2749-2753, 1993
4. Mount DB, Delpire E, Gamba G, Hall AE, Poch E, Hoover RS, Hebert SC: The electroneutral cation-chloride cotransporters. J Exp Biol 201: 2091-2102, 1998
5. Kunchaparty S, Palcso M, Berkman J, Velázquez H, Bernstein P, Reilly RF, Ellison DH: Defective processing and expression of the thiazide-sensitive Na-Cl cotransporter as a cause Gitelman's Syndrome. Am J Physiol Renal 277: 1999
6. Helenius A, Aebi M: Intracellular functions of N-linked glycans. Science 291: 2364-2369, 2001
7. Hoover RS, Poch E, Monroy A, V_ázquez N, Nishio T, Gamba G, Hebert SC: N-glycosylation at two sites critically alters thiazide binding and activity of the rat thiazide-sensitive Na+:Clcotransporter. J Am Soc Nephrol 14: 271-282, 2003
8. Tran JM, Farrell MA, Fanestil DD: Effect of ions on binding of the thiazide-type diuretic metolazone to kidney membrane. Am J Physiol 258: F908-F915, 1990
9. Ellison DH: Salt-wasting disorders. In: Acid-Base and Electrolyte Disorders, edited by DuBose TD Jr, Hamm LL, Philadelphia, Saunders, 2002, pp 311-334
10. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP: Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24-30, 1996
11. Lemmink HH, Lambert PW, van den Heuvel J, van Dijk HA, Merkx GF, Smilde TJ, Taschner PE, Monnens LA, Hebert SC, Knoers NV: Linkage of Gitelman syndrome to the thiazide-sensitive cotransporter gene with identification of mutations in three Dutch families [Abstract]. Pediatr Nephrol 10: 403-407, 1996
12. Pollak MR, Delaney VB, Graham RM, Hebert SC: Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred. J Am Soc Nephrol 7: 2244-2248, 1996
13. Lemmink HH, Knoers NV, Karolyi L, van Dijk H, Niaudet P, Antignac C, Guay-Woodford LM, Goodyer PR, Carel JC, Hermes A, Seyberth HW, Monnens LA, van den Heuvel LP: Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain [In Process Citation]. Kidney Int 54: 720-730, 1998
14. Mastrioianni N, De Fusco M, Bettinelli A, Ballabio A, Basilico E, Colussi G, Claris Appiani A, Casari G: Gitelman syndrome is caused by mutations in the human Na-Cl cotransporter gene: Molecular analysis in Italian families [Abstract]. J Am Soc Nephrol 7: 1617, 1996
15. Melander O, Orho-Melander M, Bengtsson K, Lindblad U, Rastam L, Groop L, Hulthen UL: Genetic variants of thiazidesensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension. Hypertension 36: 389-394, 2000
16. Takeuchi K, Kure S, Kato T, Taniyama Y, Takahashi N, Ikeda Y, Abe T, Narisawa K, Muramatsu Y, Abe K: Association of a mutation in thiazide-sensitive Na-Cl cotransporter with familial Gitelman's syndrome. J Clin Endocrinol Meta 81: 4496-4499, 1996
17. Schultheis PJ, Lorenz JN, Meneton P, Nieman ML, Riddle TM, Flagella M, Duffy JJ, Doetschman T, Miller ML, Shull GE: Phenotype resembling Gitelman's syndrome in mice lacking the apical Na+-Cl-cotransporter of the distal convoluted tubule [In Process Citation]. J Biol Chem 273: 29150-29155, 1998
18. Kuznetsov G, Nigam SK: Mechanisms of disease: Folding of secretory and membrane proteins. N Engl J Med 339: 1688-1695, 1998
19. Morello JP, Bichet DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001
20. Berkman J, Reilly RF, Ellison DH: Mechanisms of thiazidesensitive Na-Cl cotransporter dysfunction in Gitelman's syndrome [Abstract]. J Am Soc Nephrol 10: 1291, 1999
21. De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, Willems PH, Knoers NV, Bindels RJ: Functional Expression of Mutations in the Human NaCl Cotransporter: Evidence for Impaired Routing Mechanisms in Gitelman's Syndrome. J Am Soc Nephrol 13: 1442-1448, 2002
22. Sabath E, Meade P, Vazquez N, Berkman J, Ellison DH, Gamba G: Characterization of functional mutations in Gitelman's disease. J Am Soc Nephrol 13: 75A, 2002
23. Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB: Gitelman's syndrome revisited: An evaluation of symptoms and healthrelated quality of life. Kidney Int 59: 710-717, 2001
24. Howard M, Welch WJ: Manipulating the folding pathway of delta F508 CFTR using chemical chaperones. Methods Mol Med 70: 267-275, 2002
25. deCarvalho AV, Ndi CP, Tsopmo A, Tane P, Ayafor J, Connolly JD, Teem JL: A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTRΔF508. Mol Med 8: 75-87, 2002
26. Cruz DN, Simon DB, Nelson-Williams C, Farhi A, Finberg K, Burleson L, Gill JR, Lifton RP: Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 37: 1458-1464, 2001
27. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP: Human hypertension caused by mutations in WNK kinases. Science 293: 1107-1112, 2001
28. Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH: WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 275: 16795-16801, 2000
29. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z: Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87: 3248-3254, 2002
30. Yang C-L, Angell J, Mitchell R, Ellison DH: WNK4 downregulates thiazide-sensitive NaCl transport [Abstract]. J Am Soc Nephrol 13: 75A, 2002
31. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 157: 2413-2446, 1997
32. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321: 868-873, 1989
33. Calder JA, Schachter M, Sever PS: Potassium channel opening properties of thiazide diuretics in isolated guinea pig resistance arteries. J Cardiovasc Pharmacol 24: 158-164, 1994
34. Appel LJ: The verdict from ALLHAT - Thiazide diuretics are the preferred initial therapy for hypertension. JAMA 288:3039-3042, 2002